Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT04813133
Eligibility Criteria:
Inclusion Criteria:
1. Both males and females
2. Five years duration of clinically diagnosed type 2 Diabetes were included in the study
3. On insulin therapy
4. Diagnosed to have peripheral neuropathy according to Michigan Neuropathy Screening Instrument with a physical examination score \> 2.5
Exclusion Criteria:
1. Type 1 Diabetics
2. Type 2 Diabetics
3. On oral hypoglycemic and Glucagon-like Peptide-1 analogues, patients having neuropathies due to other causes (Vitamin B₁₂ deficiency, Drug and Alcohol abuse), patients with other co-morbidities (Renal insufficiency, Heart, Liver and Eye diseases)
4. Patients with foot ulcers and orthopedic or surgical problems of lower limb
5. Patients with peripheral vascular diseases, inability to walk independently
6. Patients receiving any structured supervised physiotherapy intervention
7. Pregnant females were excluded from the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
75 Years
Study:
NCT04813133
Study Brief:
Protocol Section:
NCT04813133